Should We Use Dialyzable β-Blockers in Hemodialysis?

• Panagiotis I. Georgianos,
• Theodoros Eleftheriadis,
• Vassilios Liakopoulos

Affiliations

Panagiotis I. Georgianos

Section of Nephrology and Hypertension, First Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Address for Correspondence: Panagiotis I. Georgianos, MD, PhD, Section of Nephrology and Hypertension, First Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, St. Kyriakidi 1, GR54636, Thessaloniki, Greece.

Theodoros Eleftheriadis

Department of Nephrology, Faculty of Medical Sciences, University of Thessaly, Larissa, Greece

Vassilios Liakopoulos

Section of Nephrology and Hypertension, First Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece